SCHEMBL3847514

SCHEMBL3847514

CSc1ccc(F)c(N=C(c2ccccc2)c2ccccc2)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.37
ESR1 P03372 3/20 0.35
ESR2 Q92731 3/20 0.35
AKR1C3 P42330 3/20 0.35
AKR1C2 P52895 3/20 0.35
AKR1C1 Q04828 2/20 0.35
GRIN2D O15399 1/20 0.34
GRIN3B O60391 1/20 0.34
SCN1A P35498 1/20 0.34
GRIN1 Q05586 1/20 0.34
GRIN2A Q12879 1/20 0.34
GRIN2B Q13224 1/20 0.34
GRIN2C Q14957 1/20 0.34
GRIN3A Q8TCU5 1/20 0.34
SCN2A Q99250 1/20 0.34
SCN3A Q9NY46 1/20 0.34
MGLL Q99685 1/20 0.33
SMN1; SMN2 Q16637 3/20 0.33
MEN1 O00255 2/20 0.33
POLB P06746 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3846753 0.76 NPC1 (0.38) GAAESR1ESR2MGLLSMN1; SMN2
SCHEMBL29220708 0.74 GAA (0.46) GAAESR1ESR2MGLLSMN1; SMN2
SCHEMBL3844695 0.73 ESR2 (0.40) GAAESR1ESR2AKR1C3AKR1C2
SCHEMBL31600570 0.67 GAA (0.35) GAAESR1ESR2MGLLSMN1; SMN2
SCHEMBL8356086 0.66 NPC1 (0.41) GAAESR1ESR2MGLLSMN1; SMN2
SCHEMBL31469943 0.66 GAA (0.40) GAAESR1ESR2GRIN2DGRIN3B
SCHEMBL29457225 0.66 ESR1 (0.38) GAAESR1ESR2MGLLSMN1; SMN2
SCHEMBL29457226 0.66 ESR1 (0.38) GAAESR1ESR2MGLLSMN1; SMN2
SCHEMBL23758436 0.66 GAA (0.44) GAAESR1ESR2SMN1; SMN2MEN1
SCHEMBL645965 0.65 ALDH1A1 (0.38) GAAAKR1C3AKR1C2MAPTMCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed